Senior insider sale
LIGAND PHARMACEUTICALS INC — senior position signals high conviction
$433.8K
2.16K shares
What this filing means
LAMATTINA JOHN L plans to sell 2.16K shares of LIGAND PHARMACEUTICALS INC valued at approximately $433.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/6/2026ACC: 0001950047-26-002309
Director
Since Sep 2018
2.16K
Shares to sell
$433.8K
Approx. market value
2.16K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
3/6/2026
2.16KTotal acquired2.16K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/6/2026 | Stock Option Exercise Cash | 2.16K | — |
| Total | 2.16K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.16K
Market value
$433.8K
3/6/2026
Total
Units
2.16K
Value
$433.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/6/2026 | 2.16K | $433.8K | NASDAQ | Planned |
| Total | 2.16K | $433.8K | ||